Proactive Investors - Run By Investors For Investors

Mediclinic in red after write-downs at Spire and in Switzerland

Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group
red
Lots of red at Mediclinic

Hospital group Mediclinic International Plc (LON:MDC) plunged into the red on write-offs on investments in Switzerland and Spire Healthcare PLC (LON:SPI).

Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group in November leading to the subsequent collapse of talks.

READ: Mediclinic nudges up guidance after strong second half for its Middle East division

Spire’s value had slumped after it paid out £37mln compensation to women treated by disgraced surgeon Ian Paterson.

South Africa-based Mediclinic, which runs hospitals in Africa, Switzerland and the Middle East,  posted a loss of £492mln in the year to March after a £109mln charge for Spire and £644mln at Swiss group Hirslanden.

Mediclinic also incurred £23mln of costs rebranding its Al-Noor acquisition.

Revenues over the year were 4% higher at £2.87bn with underlying profits 3% better at £515mln.

Shares fell 4% to 650p.

View full MDC profile View Profile

Mediclinic International Plc Timeline

Related Articles

An instrument made by Pressure BioSciences
June 26 2019
The company’s high-pressure technologies can help drug makers produce protein-based therapeutics, a market expected to touch $240 billion by 2023
pills
April 12 2019
The biotechnology company is developing a platform of unique drugs designed to prevent serious gastrointestinal damage and bleeding caused by chronic naproxen use
healthy gut
July 15 2019
Here we take a look at AIM-listed life sciences group, OptiBiotix Health

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use